In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi.

This study investigates the ability of gallium maltolate, an antimicrobial compound, to inhibit growth of the bacterium Rhodococcus equi, which often affects horses, including some strains resistant to commonly used antibiotics.

Research Objectives and Methods

• This research aimed to analyze the in vitro antimicrobial activity of a compound called gallium maltolate (GaM) against Rhodococcus equi, a bacterium which causes diseases in equines and is increasingly antibiotic-resistant. An in vitro study means the testing was done outside of living organisms, such as in a petri dish or test tube.
• It utilized 98 virulent bacterial isolates from clinical cases involving horses, with 19 of them known to be resistant to macrolides and rifampin, types of antibiotics usually utilized against Rhodococcus equi.
• The isolates were cultured with varying concentrations of GaM. Their growth was then assessed after 24 and 48 hours with measures of minimal inhibitory concentration (MIC). MIC is the lowest concentration of an antimicrobial that will prevent the growth of a microorganism. This measure allows for comparison of the bacterial isolates’ susceptibility to GaM.

Research Results

• Researchers found that both the MIC(50) and the MIC(90) after 24 hours of growth were 558 ng/mL (8 μM), and after 48 hours of growth were 2230 ng/mL (32 μM). MIC(50) and MIC(90) are values that inhibit 50% and 90% of bacterial isolates respectively. The lower the MIC value, the more effective the antimicrobial agent is at inhibiting bacterial growth.
• They observed no apparent differences in the MICs of isolates that were resistant to macrolides and those that were not. This suggests that gallium maltolate could be effective against both types of bacteria because its effectiveness does not seem to depend on the bacteria’s susceptibility to other common antibiotics. This is especially important as antibiotic resistance becomes more prevalent.

Significance of the Research

• Rhodococcus equi infections can be life-threatening to young foals, causing severe respiratory disease. Currently, these infections are becoming harder to treat due to increasing resistance to widely used antibiotics such as macrolides and rifampin.
• If gallium maltolate is found to be effective in inhibiting growth of Rhodococcus equi in live animals (in vivo), it may provide a new treatment option for antibiotic resistant infections, improving prospects for affected horses and potentially other species.